SCHEMBL9438860

SCHEMBL9438860

CN1CCN(C(c2ccc(Cl)cc2)c2cccc(Br)c2)CC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 5/20 0.71
▸ ADRA2A P08913 5/20 0.71
▸ DRD3 P35462 5/20 0.71
▸ KCNH2 Q12809 5/20 0.71
▸ CHRM1 P11229 4/20 0.71
▸ DRD1 P21728 4/20 0.71
▸ SLC6A3 Q01959 4/20 0.71
▸ ADRA1A P35348 4/20 0.71
▸ SLC6A2 P23975 3/20 0.71
▸ SLC6A4 P31645 3/20 0.71
▸ HTR1A P08908 2/20 0.71
▸ TBXA2R P21731 2/20 0.71
▸ BCL2 P10415 1/20 0.71
▸ HRH3 Q9Y5N1 1/20 0.71
▸ CYP2D6 P10635 5/20 0.69
▸ CYP2C19 P33261 2/20 0.69
▸ TSHR P16473 1/20 0.69
▸ TDP1 Q9NUW8 1/20 0.69
▸ SMN1; SMN2 Q16637 4/20 0.64
▸ OPRM1 P35372 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9439007 0.99 CYP2D6 (0.72) CHRM2ADRA2ADRD3KCNH2CHRM1
Chlorcyclizine SCHEMBL4383 0.84 KCNH2 (1.00) CHRM2ADRA2ADRD3KCNH2CHRM1
Chlorcyclizine SCHEMBL16769331 0.84 KCNH2 (1.00) CHRM2ADRA2ADRD3KCNH2CHRM1
Chlorcyclizine SCHEMBL13724147 0.84 KCNH2 (1.00) CHRM2ADRA2ADRD3KCNH2CHRM1
Chlorcyclizine SCHEMBL12157065 0.84 KCNH2 (1.00) CHRM2ADRA2ADRD3KCNH2CHRM1
SCHEMBL2056217 0.83 CHRM2 (0.86) CHRM2ADRA2ADRD3KCNH2CHRM1
Chlorcyclizine SCHEMBL321657 0.82 CYP2D6 (1.00) CHRM2ADRA2ADRD3KCNH2CHRM1
SCHEMBL9438958 0.80 CHRM2 (0.66) CHRM2ADRA2ADRD3KCNH2CHRM1
SCHEMBL10673606 0.79 DRD3 (0.68) CHRM2ADRA2ADRD3KCNH2CHRM1
Homochlorcyclizine SCHEMBL30402 0.78 DRD3 (1.00) CHRM2ADRA2ADRD3KCNH2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5364843-A Chlorophenyl methoxybenzyl-4-allylpiperazine dihydrochloride BURROUGHS WELLCOME CO. (US) 1994-11-15 — — US disclosed
EP-0409406-B1 ARYL-SUBSTITUTED AMINE DERIVATIVES USEFUL IN CANCER THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1993-09-08 — — EP disclosed
US-5124330-A (E)-ethyl 3-(4-chloro-α-(4-methyl-1-piperazinyl)benzyl)cinnamate used for potentiating the effects of antitumor agents and combating multiple drug resistance BURROUGHS WELLCOME COMPANY (US) 1992-06-23 — — US disclosed
EP-0487502-A2 Pharmaceutically active aryl-substituted amine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1992-05-27 — — EP disclosed
EP-0409406-A2 Aryl-substituted amine derivatives useful in cancer therapy THE WELLCOME FOUNDATION LIMITED (GB) 1991-01-23 — — EP disclosed
WO-1990015599-A1 MEDICAMENTS USEFUL IN CANCER THERAPY AND HAVING ANTIHISTAMINIC PROPERTIES THE WELLCOME FOUNDATION LIMITED (GB) 1990-12-27 — — WO disclosed
US-4757074-A Antihistamines BURROUGHS WELLCOME CO. (US) 1988-07-12 — — US disclosed
EP-0133323-B1 BENZHYDRYLPIPERAZINES THE WELLCOME FOUNDATION LIMITED (GB) 1988-02-03 — — EP disclosed
EP-0133323-A1 Benzhydrylpiperazines THE WELLCOME FOUNDATION LIMITED (GB) 1985-02-20 — — EP disclosed
Send feedback